Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
I. Determine the efficacy of alendronate sodium in treating osteopenia (generalized bone
density and focal bone lesions) in patients with Gaucher's disease.